|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Xa inhibitor显示文摘 | Kubitza D Becka M Voith B | | 0，，： | 1 |
| 2 | A mechanistic ap- proach for the scaling of clearance in children 显示文摘 | Edginton AN Schmitt W Voith B Willmann S | 2006 | Clin Pharmacoki- net2006，45，7： | 1 |
| 3 | Safety, pharmaco- dynamics, and pharmacokinetics of single doses of BAY 59-7939 an oral, direct factor X a inhibitor 显示文摘 | Kubitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 4 | Using the Enterion Capsule to Investigate the Absorption of Faropenem Daloxate Delivered in Particulate Form From Diff Erent Sites in the Gastrointestinal Tract显示文摘 | Connor AL Wray HA Voith B Voigt U Nagelschmitz J Kuhlmann J Wilding IR | 2001 | Pharm Sci2001，3，3： | 1 |
| 5 | Using the Enterion TM capsule to investigate the absorption of Faropenem Daloxate delivery in particulate from different sites of the gas-trointestinal tract显示文摘 | Connor AL Wray HA Voith B | 2001 | Pharm Sci2001，3，： | 1 |
| 6 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Xa inhibitor显示文摘 | KUBITZA D BECKA M VOITH B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 7 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Xa inhibitor显示文摘 | Kuhitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 8 | Safety, phannacodynam- ies, and pharmacokineties of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor 显示文摘 | Kubitza D Beeka M Voith B | 2005 | Clin Pharmacol Therapeut2005，78，4： | 1 |
| 9 | Safety, pharmacodynam- ics, and pharmacokinetics of single doses of BAY59 - 7939, an oral, direct factor Xa inhibitor 显示文摘 | Kubitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 10 | Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Ⅹa inhibitor显示文摘 | KUBITZA D BECKA M VOITH B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 11 | Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor显示文摘 | Kubitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 12 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Ⅹa inhibitor显示文摘 | Kubitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 13 | Safety, pharmacody- namics, and pharmacokinetics of single doses of BAY 59-7939,an oral, direct factor X a inhibitor显示文摘 | Kubitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，： | 1 |
| 14 | Pharmacokinetics of cerivastatin when administered under fasted and fed conditions in the morning or evening显示文摘 | Muck W Frey R Unger S Voith B | 2000 | Int J Clin Pharmacol Ther2000，38，： | 1 |
| 15 | Safety, pharmaco- dynamics, and pharmacokinetics of single doses of BAY 59- 7939, an oral, direct factor Xa inhibitor 显示文摘 | KUBITZA D BECKA M VOITH B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 16 | Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor显示文摘 | Kubitza B Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 17 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Xa inhibitor显示文摘 | Kubitza D Becka M Voith B | 2005 | C1in Pharmacol Ther2005，78，4： | 1 |
| 18 | First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone 显示文摘 | NAGELSCHMITZ J VOITH B WENSING G | 2008 | Antimierobial Agents and Chemotherapy2008，52，9： | 1 |
| 19 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct Factor Xa inhibitor显示文摘 | Kuhitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 20 | Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939 an oral, direct factor Xa inhibitor 显示文摘 | KUBITZA D BECKA M VOITH B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员